The discovery that a novel coronavirus is the probable causeof the newly recognized severe acute respiratory syndrome (SARS),reported by Ksiazek et al. (pages 1953–1966), Drostenet al. (pages 1967–1976), and Peiris et al.1 providesa dramatic example of an emerging coronavirus disease in humans,described by Poutanen et al. (pages 1995–2005), Tsanget al. (pages 1977–1985), and Lee et al. (pages 1986–1994).Although human coronaviruses cause up to 30 percent of colds,they rarely cause lower respiratory tract disease. In contrast,coronaviruses cause devastating epizootics of respiratory orenteric disease in livestock and poultry.
From the University of Colorado Health Sciences Center, Denver.
This article has been cited by other articles:
Du, L., Zhao, G., Lin, Y., Sui, H., Chan, C., Ma, S., He, Y., Jiang, S., Wu, C., Yuen, K.-Y., Jin, D.-Y., Zhou, Y., Zheng, B.-J.
(2008). Intranasal Vaccination of Recombinant Adeno-Associated Virus Encoding Receptor-Binding Domain of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Spike Protein Induces Strong Mucosal Immune Responses and Provides Long-Term Protection against SARS-CoV Infection. J. Immunol.
180: 948-956
[Abstract][Full Text]
Zhu, Z., Chakraborti, S., He, Y., Roberts, A., Sheahan, T., Xiao, X., Hensley, L. E., Prabakaran, P., Rockx, B., Sidorov, I. A., Corti, D., Vogel, L., Feng, Y., Kim, J.-O., Wang, L.-F., Baric, R., Lanzavecchia, A., Curtis, K. M., Nabel, G. J., Subbarao, K., Jiang, S., Dimitrov, D. S.
(2007). Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies. Proc. Natl. Acad. Sci. USA
104: 12123-12128
[Abstract][Full Text]
De Albuquerque, N., Baig, E., Ma, X., Zhang, J., He, W., Rowe, A., Habal, M., Liu, M., Shalev, I., Downey, G. P., Gorczynski, R., Butany, J., Leibowitz, J., Weiss, S. R., McGilvray, I. D., Phillips, M. J., Fish, E. N., Levy, G. A.
(2006). Murine hepatitis virus strain 1 produces a clinically relevant model of severe acute respiratory syndrome in a/j mice.. J. Virol.
80: 10382-10394
[Abstract][Full Text]
Prabakaran, P., Gan, J., Feng, Y., Zhu, Z., Choudhry, V., Xiao, X., Ji, X., Dimitrov, D. S.
(2006). Structure of Severe Acute Respiratory Syndrome Coronavirus Receptor-binding Domain Complexed with Neutralizing Antibody. J. Biol. Chem.
281: 15829-15836
[Abstract][Full Text]
He, Y., Li, J., Heck, S., Lustigman, S., Jiang, S.
(2006). Antigenic and Immunogenic Characterization of Recombinant Baculovirus-Expressed Severe Acute Respiratory Syndrome Coronavirus Spike Protein: Implication for Vaccine Design.. J. Virol.
80: 5757-5767
[Abstract][Full Text]
He, Y., Li, J., Li, W., Lustigman, S., Farzan, M., Jiang, S.
(2006). Cross-Neutralization of Human and Palm Civet Severe Acute Respiratory Syndrome Coronaviruses by Antibodies Targeting the Receptor-Binding Domain of Spike Protein. J. Immunol.
176: 6085-6092
[Abstract][Full Text]
Chu, V. C., McElroy, L. J., Chu, V., Bauman, B. E., Whittaker, G. R.
(2006). The Avian Coronavirus Infectious Bronchitis Virus Undergoes Direct Low-pH-Dependent Fusion Activation during Entry into Host Cells.. J. Virol.
80: 3180-3188
[Abstract][Full Text]
Maache, M., Komurian-Pradel, F., Rajoharison, A., Perret, M., Berland, J.-L., Pouzol, S., Bagnaud, A., Duverger, B., Xu, J., Osuna, A., Paranhos-Baccala, G.
(2006). False-Positive Results in a Recombinant Severe Acute Respiratory Syndrome-Associated Coronavirus (SARS-CoV) Nucleocapsid-Based Western Blot Assay Were Rectified by the Use of Two Subunits (S1 and S2) of Spike for Detection of Antibody to SARS-CoV.. CVI
13: 409-414
[Abstract][Full Text]
Hu, W., Bai, B., Hu, Z., Chen, Z., An, X., Tang, L., Yang, J., Wang, H., Wang, H.
(2005). Development and Evaluation of a Multitarget Real-Time Taqman Reverse Transcription-PCR Assay for Detection of the Severe Acute Respiratory Syndrome-Associated Coronavirus and Surveillance for an Apparently Related Coronavirus Found in Masked Palm Civets. J. Clin. Microbiol.
43: 2041-2046
[Abstract][Full Text]
Jiang, Y., Xu, J., Zhou, C., Wu, Z., Zhong, S., Liu, J., Luo, W., Chen, T., Qin, Q., Deng, P.
(2005). Characterization of Cytokine/Chemokine Profiles of Severe Acute Respiratory Syndrome. Am. J. Respir. Crit. Care Med.
171: 850-857
[Abstract][Full Text]
Chang, Y.-J., Liu, C. Y.-Y., Chiang, B.-L., Chao, Y.-C., Chen, C.-C.
(2004). Induction of IL-8 Release in Lung Cells via Activator Protein-1 by Recombinant Baculovirus Displaying Severe Acute Respiratory Syndrome-Coronavirus Spike Proteins: Identification of Two Functional Regions. J. Immunol.
173: 7602-7614
[Abstract][Full Text]
Zochodne, D. W.
(2004). SARS, SIRS, and Neurological Disease. Arch Neurol
61: 1647-1648
[Full Text]
Li, W., Greenough, T. C., Moore, M. J., Vasilieva, N., Somasundaran, M., Sullivan, J. L., Farzan, M., Choe, H.
(2004). Efficient Replication of Severe Acute Respiratory Syndrome Coronavirus in Mouse Cells Is Limited by Murine Angiotensin-Converting Enzyme 2. J. Virol.
78: 11429-11433
[Abstract][Full Text]
He, Y., Zhou, Y., Wu, H., Luo, B., Chen, J., Li, W., Jiang, S.
(2004). Identification of Immunodominant Sites on the Spike Protein of Severe Acute Respiratory Syndrome (SARS) Coronavirus: Implication for Developing SARS Diagnostics and Vaccines. J. Immunol.
173: 4050-4057
[Abstract][Full Text]
Giroglou, T., Cinatl, J. Jr., Rabenau, H., Drosten, C., Schwalbe, H., Doerr, H. W., von Laer, D.
(2004). Retroviral Vectors Pseudotyped with Severe Acute Respiratory Syndrome Coronavirus S Protein. J. Virol.
78: 9007-9015
[Abstract][Full Text]
SAMARANAYAKE, L. P., PEIRIS, M.
(2004). Severe acute respiratory syndrome and dentistry: A retrospective view. Journal of the American Dental Association
135: 1292-1302
[Abstract][Full Text]
Fielding, B. C., Tan, Y.-J., Shuo, S., Tan, T. H. P., Ooi, E.-E., Lim, S. G., Hong, W., Goh, P.-Y.
(2004). Characterization of a Unique Group-Specific Protein (U122) of the Severe Acute Respiratory Syndrome Coronavirus. J. Virol.
78: 7311-7318
[Abstract][Full Text]
Zhou, T., Wang, H., Luo, D., Rowe, T., Wang, Z., Hogan, R. J., Qiu, S., Bunzel, R. J., Huang, G., Mishra, V., Voss, T. G., Kimberly, R., Luo, M.
(2004). An Exposed Domain in the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Induces Neutralizing Antibodies. J. Virol.
78: 7217-7226
[Abstract][Full Text]
Wang, B., Chen, H., Jiang, X., Zhang, M., Wan, T., Li, N., Zhou, X., Wu, Y., Yang, F., Yu, Y., Wang, X., Yang, R., Cao, X.
(2004). Identification of an HLA-A*0201-restricted CD8+ T-cell epitope SSp-1 of SARS-CoV spike protein. Blood
104: 200-206
[Abstract][Full Text]
Lee, C.-H., Chen, R.-F., Liu, J.-W., Yeh, W.-T., Chang, J.-C., Liu, P.-M., Eng, H.-L., Lin, M.-C., Yang, K. D.
(2004). Altered p38 Mitogen-Activated Protein Kinase Expression in Different Leukocytes with Increment of Immunosuppressive Mediators in Patients with Severe Acute Respiratory Syndrome. J. Immunol.
172: 7841-7847
[Abstract][Full Text]
Wang, Y.-D., Sin, W.-Y. F., Xu, G.-B., Yang, H.-H., Wong, T.-y., Pang, X.-W., He, X.-Y., Zhang, H.-G., Ng, J. N. L., Cheng, C.-S. S., Yu, J., Meng, L., Yang, R.-F., Lai, S.-T., Guo, Z.-H., Xie, Y., Chen, W.-F.
(2004). T-Cell Epitopes in Severe Acute Respiratory Syndrome (SARS) Coronavirus Spike Protein Elicit a Specific T-Cell Immune Response in Patients Who Recover from SARS. J. Virol.
78: 5612-5618
[Abstract][Full Text]
Sui, J., Li, W., Murakami, A., Tamin, A., Matthews, L. J., Wong, S. K., Moore, M. J., Tallarico, A. St. C., Olurinde, M., Choe, H., Anderson, L. J., Bellini, W. J., Farzan, M., Marasco, W. A.
(2004). Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. Proc. Natl. Acad. Sci. USA
101: 2536-2541
[Abstract][Full Text]
Stavrinides, J., Guttman, D. S.
(2004). Mosaic Evolution of the Severe Acute Respiratory Syndrome Coronavirus. J. Virol.
78: 76-82
[Abstract][Full Text]
Hemila, H.
(2003). Vitamin C and SARS coronavirus. J Antimicrob Chemother
52: 1049-1050
[Full Text]
Drazen, J. M.
(2003). SARS -- Looking Back over the First 100 Days. NEJM
349: 319-320
[Full Text]
Previous
